Startups 2026
Rising Startup
OrganoTherapeutics SARL
Innovation & Business Idea
OrganoTherapeutics develops human, patient-specific midbrain organoids that faithfully reproduce Parkinson’s disease pathology in vitro and combines them with advanced AI-based phenotyping. This platform enables predictive, human-relevant drug testing, patient stratification, and precision medicine approaches that overcome the poor translational value of animal and 2D cell culture models.
The company provides pharmaceutical partners with highly predictive preclinical data, de-risking drug development while reducing costs and failure rates. In parallel, OrganoTherapeutics is building a proprietary data and IP position that supports its long-term vision of personalized, organoid-guided therapy decision support.
Contact
Dr Jens C. Schwamborn
jens.schwamborn@organo-therapeutics.com
https://www.organo-therapeutics.com
